Rebiotix, Ferring’s microbiome-based therapy RBX2660 shows promise
RBX2660 may bring an innovative therapeutic option to patients suffering from C. diff
Read More
Tag: Ferring
UK launch for Ferring’s new testosterone replacement therapy
Ferring Pharmaceuticals has launched testosterone replacement therapy Testavan in the UK.
Read More
SMC bars four medicines from NHS
The Scottish Medicines Consortium has rejected NHS funding for four new therapies, including Bristol-Myers Squibb and Roche’s respective cancer medicines Opdivo and Gazyvaro.
Read More
UK launch for Ferring’s Rekovelle
Ferring’s novel human recombinant follicle stimulating hormone (human rFSH) Rekovelle has now been launched across the UK for use in controlled ovarian stimulation.
Read More
EU nod for Ferring’s Rekovelle
Ferring’s Rekovelle has been approved by European regulators for controlled ovarian stimulation in women undergoing assisted reproductive technologies.
Read More
Ferring launches nocturia drug for adults of all ages
Ferring Pharmaceuticals has launched Noqdirna in the UK, offering the only licensed treatment for the symptomatic treatment of nocturia due to nocturnal polyuria in adults of all ages.
Read More
Five medicines approved for use by NHS Scotland
Patients in Scotland with thyroid cancer and lung cancer are among those who will get routine NHS access to new treatment options for their illnesses after five medicines were accepted by the Scottish Medicines Consortium.
Read More
NICE backs Ferring’s Firmagon
Men with advanced hormone-dependent prostate cancer and spinal metastases are to gain routine access to Ferring’s Firmagon on the NHS after a NICE u-turn saw the cost regulator issue final draft guidance endorsing its use.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
